$3.62
-0.13-3.34%
al cierre: -
$3.73
0.113.18%
After hour: 7:17 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
CytomX Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$-0.040
Estimación de ingresos trimestrales
$12.02M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$141.10M
Analice el historial de beneficios de CytomX Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CTMX | CytomX Therapeutics | $0.07 | -$0.04 | — | — | $33.43M | $12.02M | — | — | 11/06/2025 | |
CTMX | CytomX Therapeutics | -$0.08 | -$0.06 | $0.00 | 100.00% | $25.11M | $18.28M | $18.66M | 2.07% | 08/07/2025 | |
CTMX | CytomX Therapeutics | $0.17 | $0.13 | $0.27 | 107.69% | $41.46M | $35.42M | $50.92M | 43.75% | 05/12/2025 | |
CTMX | CytomX Therapeutics | $0.01 | -$0.11 | $0.23 | 309.09% | $26.61M | $13.04M | $38.09M | 192.12% | 03/06/2025 | |
CTMX | CytomX Therapeutics | $0.04 | -$0.17 | $0.07 | 141.18% | $26.38M | $17.51M | $33.43M | 90.93% | 11/07/2024 | |
CTMX | CytomX Therapeutics | -$0.02 | -$0.14 | -$0.08 | 42.86% | $24.72M | $19.99M | $25.11M | 25.64% | 08/08/2024 | |
CTMX | CytomX Therapeutics | -$0.05 | -$0.06 | $0.17 | 383.33% | $23.50M | $22.02M | $41.46M | 88.30% | 05/08/2024 | |
CTMX | CytomX Therapeutics | -$0.42 | -$0.03 | $0.01 | 133.33% | $946.00K | $21.04M | $26.61M | 26.46% | 03/11/2024 | |
CTMX | CytomX Therapeutics | -$0.35 | -$0.19 | $0.04 | 121.05% | $16.91M | $14.14M | $26.38M | 86.59% | 11/07/2023 | |
CTMX | CytomX Therapeutics | -$0.45 | -$0.20 | -$0.02 | 90.00% | $12.85M | $13.88M | $24.72M | 78.13% | 08/08/2023 | |
CTMX | CytomX Therapeutics | -$0.37 | -$0.11 | -$0.05 | 54.55% | $17.14M | $19.59M | $23.50M | 19.95% | 05/09/2023 | |
CTMX | CytomX Therapeutics | -$0.40 | -$0.24 | -$0.42 | -75.00% | $19.73M | $17.85M | $946.00K | -94.70% | 03/27/2023 | |
CTMX | CytomX Therapeutics | -$0.35 | -$0.31 | -$0.35 | -12.90% | $17.59M | $17.94M | $16.91M | -5.71% | 11/08/2022 | |
CTMX | CytomX Therapeutics | -$0.30 | -$0.36 | -$0.37 | -2.78% | $16.29M | $17.90M | $18.16M | 1.48% | 08/04/2022 | |
CTMX | CytomX Therapeutics | -$0.26 | -$0.36 | -$0.37 | -2.78% | $15.97M | $20.66M | $17.14M | -17.06% | 05/05/2022 | |
CTMX | CytomX Therapeutics | -$0.31 | -$0.28 | -$0.40 | -42.86% | $16.37M | $24.51M | $19.73M | -19.51% | 03/01/2022 | |
CTMX | CytomX Therapeutics | -$0.32 | -$0.31 | -$0.35 | -12.90% | $17.79M | $18.08M | $17.59M | -2.73% | 11/04/2021 | |
CTMX | CytomX Therapeutics | -$0.34 | -$0.32 | -$0.30 | 6.25% | $16.61M | $16.86M | $16.29M | -3.39% | 08/05/2021 | |
CTMX | CytomX Therapeutics | $0.26 | -$0.35 | -$0.26 | 25.71% | $49.59M | $15.43M | $15.97M | 3.51% | 05/06/2021 | |
CTMX | CytomX Therapeutics | -$0.79 | -$0.50 | -$0.31 | 38.00% | $8.28M | $15.41M | $16.37M | 6.25% | 02/24/2021 | |
CTMX | CytomX Therapeutics | -$0.52 | -$0.48 | -$0.32 | 33.33% | $10.71M | $16.34M | $17.79M | 8.86% | 11/05/2020 |
CytomX Therapeutics (CTMX) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $0 | $-0.06 | 100.0 % |
| Q1 | 2025-05-12 | $0.27 | $0.13 | 107.7 % |
| Q4 | 2025-03-06 | $0.23 | $-0.11 | 309.1 % |
| Q3 | 2024-11-07 | $0.07 | $-0.17 | 141.2 % |
CytomX Therapeutics (CTMX) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $18.66M | $18.28M | 2.07 % |
| Q1 | 2025-05-12 | $50.92M | $35.42M | 43.8 % |
| Q4 | 2025-03-06 | $38.09M | $13.04M | 192.1 % |
| Q3 | 2024-11-07 | $33.43M | $17.51M | 90.9 % |
PREGUNTAS FRECUENTES
¿Cuándo CytomX Therapeutics (NASDAQ:CTMX) publicará los resultados?
Está previsto que CytomX Therapeutics (CTMX) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de CytomX Therapeutics (NASDAQ:CTMX)?
El BPA real fue de $0.00, que superó la estimación de $-0.06.
¿Cuáles fueron los ingresos de CytomX Therapeutics (NASDAQ:CTMX)?
Los ingresos reales fueron $18.7M, que superó la estimación de $18.3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.